"Risk Assessment" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)
| Descriptor ID |
D018570
|
| MeSH Number(s) |
E05.318.740.600.800.715 N04.452.871.715 N05.715.360.750.625.700.690 N06.850.505.715 N06.850.520.830.600.800.715
|
| Concept/Terms |
Risk Assessment- Risk Assessment
- Assessments, Risk
- Risk Assessments
- Health Risk Assessment
- Assessment, Health Risk
- Assessments, Health Risk
- Health Risk Assessments
- Risk Assessment, Health
- Risk Assessments, Health
- Assessment, Risk
Benefit-Risk Assessment- Benefit-Risk Assessment
- Assessment, Benefit-Risk
- Assessments, Benefit-Risk
- Benefit Risk Assessment
- Benefit-Risk Assessments
- Risk-Benefit Assessment
- Assessment, Risk-Benefit
- Assessments, Risk-Benefit
- Risk Benefit Assessment
- Risk-Benefit Assessments
|
Below are MeSH descriptors whose meaning is more general than "Risk Assessment".
Below are MeSH descriptors whose meaning is more specific than "Risk Assessment".
This graph shows the total number of publications written about "Risk Assessment" by people in this website by year, and whether "Risk Assessment" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 2 | 2 |
| 1999 | 1 | 0 | 1 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 2 | 2 |
| 2004 | 2 | 2 | 4 |
| 2005 | 1 | 3 | 4 |
| 2006 | 0 | 2 | 2 |
| 2008 | 0 | 6 | 6 |
| 2009 | 0 | 5 | 5 |
| 2010 | 0 | 6 | 6 |
| 2011 | 0 | 9 | 9 |
| 2012 | 1 | 7 | 8 |
| 2013 | 0 | 6 | 6 |
| 2014 | 1 | 5 | 6 |
| 2015 | 2 | 11 | 13 |
| 2016 | 2 | 9 | 11 |
| 2017 | 1 | 9 | 10 |
| 2018 | 3 | 13 | 16 |
| 2019 | 2 | 10 | 12 |
| 2020 | 0 | 14 | 14 |
| 2021 | 1 | 3 | 4 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 2 | 2 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Risk Assessment" by people in Profiles.
-
Unplanned reinterventions after congenital cardiac surgery and hospital mortality: A report from the Pediatric Cardiac Critical Care Consortium (PC4). J Thorac Cardiovasc Surg. 2025 Nov; 170(5):1234-1241.e8.
-
Patient-Specific Myocardial Infarction Risk Thresholds From AI-Enabled Coronary Plaque Analysis. Circ Cardiovasc Imaging. 2024 Oct; 17(10):e016958.
-
Individualized Risk of CKD Progression among US Adults. J Am Soc Nephrol. 2024 Aug 01; 35(8):1076-1083.
-
Risks and Benefits of Different Dietary Patterns in CKD. Am J Kidney Dis. 2023 03; 81(3):352-360.
-
Warfarin Use, Stroke, and Bleeding Risk among Pre-Existing Atrial Fibrillation US Veterans Transitioning to Dialysis. Nephron. 2022; 146(4):360-368.
-
Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 21; 71(3):90-95.
-
Risk of Atherosclerotic Cardiovascular Disease and Nonatherosclerotic Cardiovascular Disease Hospitalizations for Triglycerides Across Chronic Kidney Disease Stages Among 2.9?Million US Veterans. J Am Heart Assoc. 2021 12 07; 10(23):e022988.
-
Relation of insulin treatment for type 2 diabetes to the risk of major adverse cardiovascular events after acute coronary syndrome: an analysis of the BETonMACE randomized clinical trial. Cardiovasc Diabetol. 2021 06 22; 20(1):125.
-
Metabolic syndrome, fatty liver, and artificial intelligence-based epicardial adipose tissue measures predict long-term risk of cardiac events: a prospective study. Cardiovasc Diabetol. 2021 01 29; 20(1):27.
-
The quest for cardiovascular disease risk prediction models in patients with nondialysis chronic kidney disease. Curr Opin Nephrol Hypertens. 2021 01; 30(1):38-46.